Ascend Wellness Holdings, Inc. (AAWH) Financial Statements (2026 and earlier)

Company Profile

Business Address 44 WHIPPANY ROAD, SUITE 101
MORRISTOWN, NJ 07960
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments88,25472,50874,146155,481
Cash and cash equivalent88,25472,50874,146155,481
Receivables40,64228,29817,52412,112
Inventory, net of allowances, customer advances and progress billings89,55295,29497,53265,588
Inventory89,55295,29497,53265,588
Other current assets10,92819,6449,54124,831
Financing receivable, excluding accrued interest, after allowance for credit loss✕✕13,116  
Total current assets:229,376228,860198,743258,012
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization3,2101,772997 
Operating lease, right-of-use asset139,067130,556108,810103,958
Property, plant and equipment    239,656
Intangible assets, net (including goodwill)255,101268,990265,463102,238
Goodwill49,59947,53844,37042,967
Intangible assets, net (excluding goodwill)205,502221,452221,09359,271
Other noncurrent assets16,42623,06219,28419,572
Other undisclosed noncurrent assets257,251266,310278,863 
Total noncurrent assets:671,055690,690673,417465,424
TOTAL ASSETS:900,431919,550872,160723,436
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:59,43571,11256,59545,454
Interest and dividends payable✕✕✕✕187
Employee-related liabilities✕✕✕✕11,760
Accounts payable26,41434,68717,0655,536
Accrued liabilities31,74030,68716,8106,809
Other undisclosed accounts payable and accrued liabilities1,2815,73822,72021,162
Deferred revenue1,3941,317672518
Debt73,88111,14811,32927,940
Other liabilities5,0606,7665,7145,152
Other undisclosed current liabilities4,7712,34336,63938,331
Total current liabilities:144,54192,686110,949117,395
Noncurrent Liabilities
Long-term debt and lease obligation, including:234,542297,565319,297428,141
Long-term debt, excluding current maturities    230,846
Finance lease, liability2,0211,196695 
Other undisclosed long-term debt and lease obligation232,521296,369318,602 
Liabilities, other than long-term debt449,547386,427278,4991,423
Deferred income tax liabilities23,43935,74533,6071,423
Other liabilities158,88789,59515,076 
Operating lease, liability267,221261,087229,816197,295
Total noncurrent liabilities:684,089683,992597,796429,564
Total liabilities:828,630776,678708,745546,959
Equity
Equity, attributable to parent, including:70,978142,872163,415176,477
Additional paid in capital471,129458,027430,375362,555
Accumulated deficit(400,356)(315,362)(267,148)(186,249)
Other undisclosed equity, attributable to parent205207188171
Equity, attributable to noncontrolling interest823   
Total equity:71,801142,872163,415176,477
TOTAL LIABILITIES AND EQUITY:900,431919,550872,160723,436

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenues561,599518,590405,926332,381
Cost of revenue(377,389)(363,470)(271,363)(196,409)
Gross profit:184,210155,120134,563135,972
Operating expenses(179,476)(158,739)(142,089)(153,176)
Operating income (loss):4,734(3,619)(7,526)(17,204)
Nonoperating expense(44,556)(11,141)(31,680)(63,733)
Other nonoperating income70725,843756256
Interest and debt expense(5,475)(36,984)(2,180)(6,637)
Loss from continuing operations before equity method investments, income taxes:(45,297)(51,744)(41,386)(87,574)
Other undisclosed income from continuing operations before income taxes5,47536,9842,1806,637
Loss from continuing operations before income taxes:(39,822)(14,760)(39,206)(80,937)
Income tax expense(45,172)(33,454)(41,693)(41,720)
Loss from continuing operations:(84,994)(48,214)(80,899)(122,657)
Loss before gain (loss) on sale of properties:✕✕✕✕(122,657)
Net loss available to common stockholders, diluted:(84,994)(48,214)(80,899)(122,657)

Comprehensive Income ($ in thousands)
Annual | Quarterly

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(84,994)(48,214)(80,899)(122,657)
Comprehensive loss, net of tax, attributable to parent:(84,994)(48,214)(80,899)(122,657)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: